Report Top Up a Page Previous Next Up a Map TOC Page Index File Index What's New Page Bottom
Cognigen Corporation - Posters and Presentations : Pre-2006 : 2002 : ACCP 2002 : Factors Influencing the Pharmacokinetics (PD) of Anticancer Drug Irinotecan (CPT-11) and its Major Metabolites, SN-38 and SN38G published Mon, Nov 10, 2008 - 15:27 EST

Factors Influencing the Pharmacokinetics (PD) of Anticancer Drug Irinotecan (CPT-11) and its Major Metabolites, SN-38 and SN38G

Primary Author: Alan J. Xiao

Author: Alan J. Xiao, Ph.D.

Sponsor: Pharmacia Corporation

Event: American College of Clinical Pharmacology - September 2002

Other Contributors:

Cognigen: Jill Fiedler-Kelly, M.S.

Pharmacia: Larry J. Schaaf, James P. McGovren, Gary L. Elfring

Download this PDF file. (Instructions for downloading)
Page authored by Cognigen Corporation

Cognigen Corporation - Posters and Presentations : Pre-2006 : 2002 : ACCP 2002 : Factors Influencing the Pharmacokinetics (PD) of Anticancer Drug Irinotecan (CPT-11) and its Major Metabolites, SN-38 and SN38G published Mon, Nov 10, 2008 - 15:27 EST
Report Top Up a Page Previous Next Up a Map TOC Page Index File Index What's New Page Top